# Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel

> **NCT00368316** · PHASE3 · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 2799 (actual)

## Conditions studied

- Shigellosis

## Interventions

- **BIOLOGICAL:** Shigella conjugate vaccines

## Key facts

- **NCT ID:** NCT00368316
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2008-01
- **Final completion:** 2009-02
- **Target enrollment:** 2799 (ACTUAL)
- **Last updated:** 2012-06-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368316, "Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00368316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*